The perfusion systems market has seen considerable growth due to a variety of factors.
•In the past few years, the perfusion systems market has shown remarkable growth. The market size, which stood at $1.33 billion in 2024, is expected to rise to $1.46 billion in 2025, following a compound annual growth rate (CAGR) of 9.8%.
Significant factors contributing to this growth during the historic period include fundamental research in perfusion science, the use of hypothermia techniques, the emergence of cardiopulmonary bypass, and the development of the first heart-lung machine.
The perfusion systems market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for swift expansion of the perfusion systems market in the coming years, with projections placing it at "$2.15 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.2%.
Factors propelling growth in the forecast period include emphasis on patient results, an increase in cardiovascular surgeries, broader use of minimally invasive procedures, escalated use of ECMO, enhancement of global healthcare infrastructure, and the swelling of the elderly population. The forecast period is also predicted to see trends such as the emergence of portable and compact designs, integration of automatic and robotic systems, advancements in remote monitoring and telemedicine, the rise of adaptable and custom-made platforms, sophisticated data analytics, and AI.
The growth of the perfusion systems market is projected to be driven by the increasing rate of organ transplants. An organ transplant involves a surgical process in which a defective or damaged organ is taken from a donor to be transplanted into a patient in need due to organ disease or failure. Perfusion systems, which play an essential role in preserving and transporting organs during the transplant operation, are crucial for the viability of the donated organs. The Organ Procurement And Transplantation Network, a non-profit organization based in the US, reported in January 2021 that 41,354 organ transplants had taken place in the US. This figure signals a growth of 5.9% from the number of transplants carried out in 2020. Consequently, the perfusion systems market is experiencing increased demand due to the surge in the number of organ transplants.
The perfusion systems market covered in this report is segmented –
1) By Product: Cardiopulmonary Perfusion System, Extracorporeal membrane oxygenation (ECMO), Isolated Organ Perfusion Systems, Other Products
2) By Type Of Organ: Heart, Lung, Kidney, Liver, Other Type Of Organs
3) By Technique: Hypothermic, Normothermic
4) By End-User: Hospital, Clinic, Ambulatory Surgical Centers, Other End-users
Subsegments:
1) By Cardiopulmonary Perfusion System: Heart-Lung Machines, Blood Pumps, Oxygenators
2) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Arterial (VA) ECMO Systems, Veno-Venous (VV) ECMO Systems, Portable ECMO Systems
3) By Isolated Organ Perfusion Systems: Liver Perfusion Systems, Kidney Perfusion Systems, Heart Perfusion Systems
4) By Other Products: Vascular Cannulae, Heat Exchangers, Perfusion Monitoring Systems
The rise of product innovation stands as a critical trend in the perfusion systems market. Top players in the perfusion systems market are focusing on producing novel products to enhance their market footprint. For example, LivaNova, a UK firm specializing in neuromodulation devices and cardiopulmonary products, in February 2023, unraveled the Essenz perfusion system in Europe. This compact, modular and transportable cardiopulmonary bypass (CPB) system is customized for conducting cardiac surgeries. The system's modularity allows customization to suit specific patient requirements and surgical procedures. Its compact and mobile characteristics facilitate ease of transportation and arrangement in various clinical environments.
Major companies operating in the perfusion systems market include:
• Getinge AB
• Medtronic plc
• LivaNova PLC
• Terumo Corporation
• Lifeline Scientific Inc.
• XVIVO Perfusion AB
• Repligen Corporation
• Spectrum Laboratories Inc.
• Merck KGaA
• Harvard Bioscience Inc.
• ALA Scientific Instruments Inc.
• XENIOS AG
• Siemens Healthcare Private Limited Shimadzu Corporation
• GENERAL ELECTRIC COMPANY
• Organ Assist Products B.V.
• Hitachi Ltd.
• Bioptechs Inc.
• Cytiva Company
• Sorin Group
• Organ Recovery Systems Inc.
• TransMedics Inc.
• Paragonix Technologies Inc.
• Bridge to Life (Europe) Ltd.
• OrganOx Limited
• Preservation Solutions Inc.
North America was the largest region in the perfusion systems market in 2024. The regions covered in the perfusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa